A new general USP Chapter <1083> Good Distribution Practices - Supply Chain Integrity has been presented in the new issue of the USP Pharmacopeial Forum (volume 38, edition 2).
The main issue of the new chapter focuses on counterfeited medicines. Here are the topics which are dealt with in detail:
A paragraph entitled "Best Practices to combat Counterfeit Drugs and Medical Devices" presents a range of measures and possibilities to combat counterfeit medicines:
Pharmaceutical manufacturers should establish a global and dedicated team to oversee product security. Furthermore, measures and steps are recommended when a counterfeit product or suspected counterfeit product is detected in the supply chain. The new chapter will be added to USP 36.
To view the document, you need to register for the Pharmacopeial Forum.
At the Anti-Counterfeit Conference - Strategies against Falsified / Counterfeit Medicines - organised by the University of Würzburg on 7 - 8 May 2012, Dr Leigh Verbois from the Office of Drug Security, Integrity, and Recalls, CDER, FDA, USA will present the new FDA Supply Chain Integrity Initiatives (via Video Conference).
Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
联系客服